Home
News
Create
Screeners
Insights
Astonea Labs
159.
60
-159.60
(-100.00%)
Market Cap
₹167.80 Cr
PE Ratio
31.36
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-100.00%
1M
-100.00%
6M
-100.00%
1Y
-100.00%
5Y
-100.00%
View Company Insights
Latest news about Astonea Labs
Astonea Labs Completes ₹6.25 Crore Acquisition of 25.74% Stake in Damaira Pharmaceuticals
3 days ago
Astonea Labs Limited has successfully completed the acquisition of a 25.74% equity stake in Damaira Pharmaceuticals Private Limited for ₹6.25 crore, utilizing funds from reallocated IPO proceeds. The transaction involved acquiring 52,00,000 equity shares at ₹12.02 per share and represents a strategic investment to expand the company's pharmaceutical sector footprint and create operational synergies.
Astonea Labs Adopts New Articles of Association at March 27 EGM
7 days ago
Astonea Labs Board Approves IPO Proceeds Variation and Related Party Transactions Worth Rs. 415 Crore
Feb 27, 2026
Astonea Labs Limited Incorporates Wholly-Owned US Subsidiary for Pharmaceutical Business Expansion
Jan 26, 2026
Astonea Labs Reports Strong Half-Year Results and Appoints Three New Directors
Nov 11, 2025
More news about Astonea Labs
20
Sept 25
Astonea Labs' Company Secretary Resigns, Trading Window to Close
Astonea Labs Limited reported significant corporate changes. Vijay Kumar, Company Secretary and Compliance Officer, resigned effective September 20, 2025. The company also announced the closure of its trading window from October 1, 2025, for insiders and related parties, in compliance with SEBI regulations. This closure will remain until 48 hours after the declaration of Un-Audited Financial Results for the half-year ending September 30, 2025.
Astonea Labs
159.
60
-
159.
60
(-
100.
00
%)
1 Year Returns:
-100.00%
Industry Peers
Sun Pharmaceutical
1,693.60
(-
2.
02
%)
Divis Laboratories
5,856.50
(-
0.
85
%)
Torrent Pharmaceuticals
3,987.20
(-
3.
02
%)
Lupin
2,274.50
(-
0.
02
%)
Dr Reddys Laboratories
1,217.30
(+
0.
64
%)
Cipla
1,192.40
(-
0.
29
%)
Zydus Life Science
864.25
(+
0.
12
%)
Mankind Pharma
1,998.50
(-
0.
14
%)
Aurobindo Pharma
1,333.70
(-
0.
63
%)
Alkem Laboratories
5,258.00
(+
0.
26
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO